Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Infinity Pharmaceuticals Inc (INFIQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.018 +0.000    +0.00%
06/02 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.018 - 0.018
Infinity 0.018 +0.000 +0.00%

Infinity Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of Infinity Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

30

Equity Type

ORD

Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company’s product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. Infinity Pharmaceuticals, Inc. has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Cambridge, Massachusetts. On September 29, 2023, Infinity Pharmaceuticals, Inc. along with its affiliate, a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. The plan was later approved as Chapter 11 liquidation on March 7, 2024.

Contact Information

Address 1100 Massachusetts Avenue Floor 4
Cambridge, 02138
United States
Phone 617 453 1000
Fax 617 453 1001

Top Executives

Name Age Since Title
Anthony B. Evnin 82 2006 Independent Director
Dmitry I. Gabrilovich - 2018 Member of Scientific Advisory Board
David William Beier 74 2018 Independent Director
Norman C. Selby 71 2012 Lead Independent Director
F. Stephen Hodi - 2018 Member of Scientific Advisory Board
Jeffery L. Kutok 56 2017 Chairman of Scientific Advisory Board
Samuel Agresta 50 2018 Chair of Clinical Advisory Board
David H. Munn - 2018 Member of Scientific Advisory Board
Roy Steven Herbst 60 2018 Member of Scientific Advisory Board
Padmanee Sharma - - Member of Clinical Advisory Board
Michael Postow - - Member of Clinical Advisory Board
Toni K. Choueiri - - Member of Clinical Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

INFIQ Comments

Write your thoughts about Infinity Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Scott Ornelas
Jatslo Oct 18, 2021 1:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
INFI (T) 1.4 3.5691
Ryan Humphreys
PutsmyCall Aug 03, 2021 2:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought 2.47 going for double
Mar 26, 2021 5:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$9 by the end of this month
Kyle Butler
OldToby Mar 26, 2021 5:17PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any more predcitions?
Mike Price
Mike Price Mar 02, 2021 11:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any news ..updates?
Mike Price
Mike Price Feb 10, 2021 11:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any news or updates...buy sell hold?
Carlos Deterville
Carlos Deterville Feb 10, 2021 11:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
offering at 3,80
Mike Price
Mike Price Feb 10, 2021 11:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what does that mean
Glenn AM
Glenn AM Feb 04, 2021 6:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what is the marketabiliity of the product to generate income?
Future Smells Like Elon Musk
Future Smells Like Elon Musk Jan 07, 2021 11:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why did I buy this....ugh.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email